Total Payments
$6,613
2024 Payments
$1,143
Companies
36
Transactions
337
Medicare Patients
22,472
Medicare Billing
$1.1M
Payment Breakdown by Category
Food & Beverage$6,585 (99.6%)
Education$27.78 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,585 | 336 | 99.6% |
| Education | $27.78 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,142 | 71 | $0 (2024) |
| Novo Nordisk Inc | $843.31 | 43 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $676.98 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $619.81 | 11 | $0 (2024) |
| GlaxoSmithKline, LLC. | $458.13 | 16 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $381.08 | 26 | $0 (2023) |
| PFIZER INC. | $278.57 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $267.66 | 7 | $0 (2023) |
| Amgen Inc. | $265.19 | 11 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $218.06 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,143 | 66 | Novo Nordisk Inc ($368.37) |
| 2023 | $967.93 | 38 | Novo Nordisk Inc ($286.94) |
| 2022 | $1,307 | 86 | ABBVIE INC. ($330.16) |
| 2021 | $1,127 | 46 | AbbVie Inc. ($253.22) |
| 2020 | $555.58 | 28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($229.93) |
| 2019 | $631.22 | 32 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($174.80) |
| 2018 | $624.05 | 24 | Janssen Pharmaceuticals, Inc ($249.87) |
| 2017 | $257.09 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($72.55) |
All Payment Transactions
337 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: VACCINE | ||||||
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.26 | General |
| Category: Diabetes | ||||||
| 12/08/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.65 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $6.25 | General |
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.10 | General |
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), VIBERZI, CREON | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: RESPIRATORY | ||||||
| 10/25/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Oncology | ||||||
| 10/18/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.05 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.35 | General |
| 10/08/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Obesity | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Gastroenterology | ||||||
| 09/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: Obesity | ||||||
| 08/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Obesity | ||||||
| 08/13/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.42 | General |
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Biological | ||||||
| 08/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 5,348 | 6,867 | $1.1M | $276,432 |
| 2022 | 32 | 5,768 | 7,232 | $1.0M | $290,779 |
| 2021 | 36 | 6,129 | 7,495 | $948,773 | $305,554 |
| 2020 | 30 | 5,227 | 6,237 | $759,988 | $213,176 |
Total Patients
22,472
Total Services
27,831
Medicare Billing
$1.1M
Procedure Codes
130
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 666 | 1,450 | $601,915 | $153,683 | 25.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $110,715 | $26,816 | 24.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 262 | $79,580 | $20,903 | 26.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 429 | 477 | $36,735 | $7,823 | 21.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 36 | 36 | $28,440 | $6,675 | 23.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 436 | 492 | $31,080 | $6,445 | 20.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 83 | 83 | $23,240 | $6,292 | 27.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 464 | 576 | $25,340 | $5,950 | 23.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 495 | 661 | $21,815 | $5,552 | 25.5% |
| 84480 | Thyroid hormone, t3 measurement, total | Office | 2023 | 270 | 303 | $25,560 | $4,198 | 16.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 453 | 547 | $18,595 | $4,149 | 22.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 111 | 111 | $10,295 | $3,994 | 38.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $14,285 | $3,936 | 27.6% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 435 | 481 | $16,615 | $3,225 | 19.4% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 21 | 21 | $9,240 | $3,003 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 239 | 254 | $38,925 | $2,733 | 7.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 125 | 127 | $10,795 | $2,275 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 111 | 120 | $5,840 | $1,142 | 19.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $4,780 | $1,108 | 23.2% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 21 | 21 | $2,520 | $1,007 | 40.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 29 | 29 | $3,450 | $916.38 | 26.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 247 | 253 | $3,795 | $782.87 | 20.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $2,190 | $701.48 | 32.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 17 | 17 | $1,615 | $611.66 | 37.9% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2023 | 14 | 14 | $2,145 | $578.06 | 26.9% |
About Dr. Kenneth Ackerman, M.D
Dr. Kenneth Ackerman, M.D is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033205265.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Ackerman, M.D has received a total of $6,613 in payments from pharmaceutical and medical device companies, with $1,143 received in 2024. These payments were reported across 337 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,585).
As a Medicare-enrolled provider, Ackerman has provided services to 22,472 Medicare beneficiaries, totaling 27,831 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Great Neck, NY
- Active Since 10/05/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033205265
Products in Payments
- XIFAXAN (Drug) $698.56
- XARELTO (Drug) $619.81
- UBRELVY (Drug) $583.36
- TRELEGY ELLIPTA (Drug) $379.08
- NURTEC ODT (Drug) $340.34
- Livalo (Drug) $263.36
- Ozempic (Drug) $262.49
- JARDIANCE (Drug) $234.00
- Wegovy (Drug) $217.44
- VRAYLAR (Drug) $207.74
- QULIPTA (Drug) $177.36
- Vascepa (Drug) $165.97
- Trintellix (Drug) $131.40
- CREON (Drug) $129.38
- ELIQUIS (Drug) $124.56
- Aimovig (Biological) $92.87
- Otezla (Drug) $86.07
- JANUVIA (Drug) $82.20
- CHANTIX (Drug) $78.97
- TRULICITY (Drug) $78.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163
Internal Medicine $15,163